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R565That dynactin is not utilized in these
processes further suggests that
processive motility — which is
enhanced by dynactin — is not needed
for at least some mitotic functions of
dynein. Finally, at least one aspect
of mitosis — centrosome attachment
to the NE — required both regulators,
indicating that perhaps centrosome
anchoring is more complex than
appreciated.
As is often the case, new results raise
new questions (Figure 1). Where does
dynein function in the spindle to
generate force for chromosomemotion
and to oppose kinesin-5? Is dynein
tethered on one microtubule while
holding on to an adjacent microtubule?
It will be interesting to see how dynein
does it without dynactin.References
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of PericytesGlioblastoma stem cells have been reported to directly contribute to the tumor
vasculature by endothelial cell differentiation. Interestingly, a recent study
demonstrates that glioblastoma stem cells preferentially differentiate into
vascular pericytes to support vasculature function and tumor growth.Allan Yi Liu and Gaoliang Ouyang*
Blood vessels are indispensable for
solid tumor development not only for
delivering oxygen and nutrients but
also for disposing of carbon dioxide
and metabolic waste. Meanwhile,
blood vessels also serve as important
routes for malignant cells to
metastasize to distant organs.
Endothelial cells and pericytes are two
distinct types of cell in the blood vessel
wall. Endothelial cells line the inner
surface of vessels and pericytes attach
to endothelial cells to support
neovasculature function. Current
opinions suggest that, in tumors,pericytes are derived from their
progenitors in the surrounding normal
tissue or from bone-marrow-derived
cells, whereas tumor endothelial cells
come from local vessels, circulating
endothelial progenitor cells, or
mesenchymal stem cells with
endothelial properties. Glioblastoma
is a highly angiogenic and lethal
malignancy containing tumorigenic
glioblastoma stem cells [1–3].
Glioblastoma stem cells have been
reported to directly contribute to
the tumor vasculature by
transdifferentiating into endothelial
cells [4,5]. Glioblastoma stem cells
and neural stem cells have manysimilar properties, such as the
ability to transdifferentiate into
endothelial cells, with neural stem cells
also having the ability to
transdifferentiate into pericytes [6,7].
However, whether glioblastoma stem
cells had the ability to generate
vascular pericytes in tumor
angiogenesis remained unknown until
a new study recently published in
Cell by Cheng et al. [8], which now
demonstrates that glioblastoma stem
cells have the potential to generate
pericytes to support vessel function
and tumor growth.
In this new work, these authors
found that a fraction (4–11%) of the
differentiated cells derived from
glioblastoma stem cells and
tumorspheres under differentiation
conditions in vitro are pericytes. Cheng
et al. [8] further discovered that the
majority of vascular pericytes
(57–89%), but none of the endothelial
cells, are derived from glioblastoma
stem cells in glioblastoma xenografts.
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Figure 1. Differentiation of glioblastoma stem cells into pericytes in the tumor vascular niche.
Cancer stem cells are multipotent cells that have the potential to give rise to different cell
lineages. In vascular niches, tumor cells, endothelial cells and other stromal cells secrete
many growth factors, cytokines and chemokines into the tumor microenvironment. Glioblas-
toma stem cells can be recruited towards endothelial cells via SDF-1–CXCR4 chemokine
signaling. When triggered by TGF-b, glioblastoma stem cells differentiate mostly into pericytes
and attach to endothelial cells to support vessel function. Glioblastoma stem cells also give
rise to endothelial cells in some circumstances, but the differentiation efficiency is relatively
low. Activated Notch signaling converts glioblastoma stem cells into endothelial progenitors,
and endothelial differentiation is then regulated by VEGF to support tumor angiogenesis. Un-
der appropriate environmental stimuli, glioblastoma stem cells can undergo mesenchymal
differentiation. Therefore, glioblastoma stem cells and their derived cells, together with normal
tissue-derived cells, contribute to tumor angiogenesis and tumor growth.
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the presence of pericytes derived from
glioblastoma stem cells. Furthermore,
the authors performed fluorescence in
situ hybridization (FISH) to analyze the
genetic changes in the pericytes and
endothelial cells from human primary
glioblastoma samples: genetic
alterations could be detected in the
majority of tumor pericytes (58–83%)
but rarely in endothelial cells in these
glioblastomas. Similar results were
obtained by FISH analyses on the
pericytes and endothelial cells sorted
from the human primary glioblastomas.
Finally, the authors demonstrated that
glioblastoma stem cells can be
recruited towards endothelial cells via
SDF-1–CXCR4 chemokine signaling
and that TGF-b contributes to the
production of pericytes from
glioblastoma stem cells (Figure 1).
Theoretically, glioblastoma stem
cells aremultipotent stem cells that can
give rise to different types of cells inspecific conditions. Previous evidence
reported in Nature showed that
glioblastoma stem cells can
differentiate into endothelial cells
in vitro and in vivo [4,5]. Interestingly,
Cheng et al. [8] find that glioblastoma
stem cells preferentially differentiate
into pericytes but not endothelial
cells [8]: although cells expressing
endothelial markers were detected in
cells differentiated from glioblastoma
stem cells in culture, the numbers were
very low (<0.6%). Cheng et al. [8] could
not observe the glioblastoma stem
cell derived endothelial cells in vivo
by complementary lineage tracing
methods. The possible discrepancies
between the previous Nature papers
[4,5] and the story in Cell [8] might
partly result from the different
endothelial cells analyzed in these
reports. Genetic changes are rarely
detected in tumor endothelial cells in
human primary glioblastoma tissue
microarrays [8]; however, geneticalterations are more often detected in
the endothelial cells sorted fromhuman
primary glioblastomas or xenografts
using endothelial markers [4,5]. So,
it is quite possible that some
non-endothelial cells in the tumor that
express endothelial markers were
sorted and mixed with tumor
endothelial cells in the sorting process.
Interestingly, the percentage of
glioblastoma stem cell derived
endothelial cells from the total tumor
endothelial cells in the genetic
glioblastoma mouse model is 10–25%
[9], which is much lower than that in the
glioblastoma neurosphere xenograft
model (nearly 70%) [4]. However, a
significant fraction of tumor pericytes
(mean 76%) was found to carry the
same genetic alterations as cancer
cells in human primary glioblastoma
tissue microarrays. The majority of
tumor pericytes (mean 63%) express
tumor-specific PDGFB in the
genetically engineered mouse
glioblastoma models [8]. Therefore,
the glioblastoma xenograft model
probably overamplified the endothelial
differentiation from glioblastoma stem
cells in the Nature papers [4,5].
In addition, stem cells can acquire
phenotypes of other types of cells
by cell fusion. However, this
cell-fusion-dependent event is easily
mistaken for stem cell plasticity. This
raises the possibility that cell fusion
of glioblastoma stem cells with
endothelial cells or pericytes might
contribute to the discrepancies.
Tumor-derived endothelial cells have
been shown to originate from
glioblastoma stem cells but not from
cell fusion of endothelial cells and
tumor cells [4,5,9]. Cheng et al. [8]
did not provide direct evidence that
pericyte differentiation from
glioblastoma stem cells is fusion
independent; however, they
demonstrated, using an in vivo cell
lineage tracing system with
pericyte-specific promoter-driven
fluorescent reporters and a genetically
engineered mouse glioblastoma
model, that glioblastoma stem cells
generate the majority of vascular
pericytes [8]. Collectively, glioblastoma
stem cells preferentially give rise
to pericytes in glioblastoma
pathogenesis, whereas conversion
from glioblastoma stem cells to
endothelial cells occurs at a relatively
low rate. Further work is required
to define the switch in endothelial and
pericyte differentiation of glioblastoma
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R567stem cells and to identify other
factors that determine the preferential
differentiation of glioblastoma stem
cells into pericytes.
Cancer stem cells are a small fraction
of cancer cells that have the potential
to drive tumorigenesis and metastatic
growth [10,11]. These stem cells are
present in nearly all solid tumors,
although cancer stem cell models are
controversial for some tumors.
Are cancer stem cells the cell origin of
tumor vessels in other cancers?
Several groups have reported that
tumor endothelial cells carry genetic
changes similar to tumor cells in
melanoma, liposarcoma, and
neuroblastoma [12,13]. Moreover,
human breast cancer stem/progenitor
cells can undergo endothelial
differentiation in vitro and give rise to
tumor endothelial cells in a xenograft
model [14]. Stem-like ovarian cancer
cells can function as endothelial
progenitors and differentiate into
endothelial cells under proper
conditions in vitro [15]. In addition,
vasculogenic mimicry refers to the
plasticity of cancer cells mimicking
the abilities of endothelial cells to
form de novo vascular networks and
is identified in various tumors [16].
Therefore, whether cancer stem cells
in other malignant tumors give rise to
endothelial cells deserves further
investigation. Meanwhile, thus far the
tumor origin of pericytes in other kinds
of cancers has not yet been reported.
It will be interesting to see whether
the ability of cancer stem cells to
transdifferentiate into tumor vascular
pericytes is a universal phenomenon,
occurring in other highly vascular
malignancies. Another important issue
raised by these studies is whether
glioblastoma stem cells can
transdifferentiate into other stromal
cells in addition to pericytes,
endothelial cells, and non-stem
glioblastoma tumor cells in the
glioblastoma microenvironment
to promote tumor growth and
progression. Long-term cultured
pericytes have been reported to
have the ability to differentiate into
multiple lineages like mesenchymal
stem cells [17]. So, can pericytes give
rise to other kinds of stroma cells
in the tumor microenvironment to
promote tumor progression?
Additionally, whether the glioblastoma
stem cell derived pericytes
(G-pericytes) in glioblastomas revert
by de-differentiation in vivo to cancercells with stem-like properties and
malignant potential remains to be
elucidated.
It is very interesting to note that
selective elimination of G-pericytes
in vivo leads to the disruption of
endothelial walls and collapse of vessel
lumens, thus impairing glioblastoma
tumor growth and progression [8].
Therefore, selective targeting of
G-pericytes may improve the efficacy
of anti-glioblastoma therapy.
Conventional anti-angiogenesis
therapies are mostly based on the
inhibition of vascular endothelial
growth factor (VEGF) and targeting
of endothelial cells alone. Although
anti-VEGF drug treatment brings
benefits to some cancer patients,
the long-term, disease-free survival
beyond three years is still not
optimistic. Also anti-angiogenic
therapies have the unfortunate
potential to trigger a more invasive and
metastatic phenotype in some tumors
[18]. Pericytes attach to endothelial
cells and interact with endothelial cells
to support vasculature growth and
maintain vessel integrity as well as
promote resistance of endothelial
cells to anti-angiogenesis therapies.
Pericytes can protect endothelial cells
from VEGF withdrawal by activating
alternative pro-angiogenic pathways,
especially PDGF receptor signaling
in anti-VEGF therapy [18]. Thus,
combination targeting of endothelial
cells and pericytes might make
tumor vessels more sensitive to
anti-angiogenic treatment in
glioblastomas. Moreover, brain tumors
exploit vascular niches to maintain
their cancer stem cell pool [19].
Glioblastoma stem cells give rise to
vascular pericytes that may constantly
remodel perivascular niches.
Therefore, targeting endothelial cells
and pericytes simultaneously probably
destroys the glioblastoma stem cell
niches to promote tumor regression
and reduce tumor recurrence.
Furthermore, large fractions of
pericytes in glioblastoma vascular
niches are derived from glioblastoma
stem cells and harbor the same genetic
mutations as glioblastoma cells;
however, the remaining pericytes
maintain a normal phenotype [8].
The functional differences between
normal pericytes and G-pericytes
are still unknown. Elucidating the
mechanism underlying these functional
differences may provide potential
novel targets for anti-angiogenesistherapy. Of note, pericytes also have
roles beyond supporting vessel
function and promoting angiogenesis
in tumor growth. A low number of
vessel-associated pericytes or
absence of pericyte coverage is
correlated with increased metastasis
in colorectal, prostate, pancreatic and
invasive breast cancers [20]. Therefore,
therapeutic strategies that target
pericytes should be determined for
specific pathological conditions. In any
case, the identification of the lineage
plasticity and capacity of glioblastoma
stem cells to differentiate into tumor
vascular pericytes provides new insight
into the complicated association
between glioblastoma stem cells and
vascular cells within glioblastomas,
as well as the implications for targeting
G-pericytes in anti-glioblastoma
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In the 1998 movie The Truman Show,
Jim Carrey plays Truman Burbank, a
character who is initially unaware of the
fact that his entire life is meticulously
controlled and broadcast as a
television show. Researchers studying
animal behavior can often only dream
of obtaining similarly detailed
behavioral and life-history data for their
study organisms. In a recent paper,
Danielle Mersch and colleagues [1]
describe a new setup built to
continuously and simultaneously
follow hundreds of individual ants
inside colonies over extended
periods of time — not unlike the
spectators of The Truman Show were
following the life of Truman Burbank.
The initial data from this study reveal
the patterns of division of labor and the
structure of interaction networks in
insect societies in unprecedented
detail. The new tracking setup will
facilitate a plethora of quantitative
behavioral studies of social insects in
the future.
The colonies of social insects, such
as ants, bees, or termites, are among
the most complex animal societies on
Earth, displaying communal
architecture and sophisticatedcommunication [2]. Division of labor is
arguably the most important aspect of
social organization in insect colonies.
While queens lay eggs, workers
perform the tasks associated with
brood care, nest construction, and
colony maintenance. Some workers
forage to gather food, while others
nurse the brood, clean the nest, or
defend the colony against enemies
and competitors [2]. Division of labor
allows insect societies not only to
perform different tasks simultaneously,
but also to produce specialized classes
of individuals, so-called ‘castes’, that
excel at a particular task, often at the
expense of performance at other
tasks. An insect colony can therefore
function as a jack of all trades, and
master of all. Not surprisingly then,
social insects are highly successful
and ecologically dominant in most
terrestrial ecosystems [3]. While
insect sociogenesis, which E.O. Wilson
defined as ‘‘the process by which
colony members undergo changes
in caste, behavior, and physical
location incident to colonial
development’’ [4] has been the
subject of intense study, many major
questions remain poorly understood.
For instance, what determines the
behavior of a given individual and
how is its role in the society assignedin the absence of a centralized
control? How exactly are colony
function and homeostasis achieved as
the external environment and colony
needs change over time? And how
does division of labor relate to colony
fitness?
These questions are daunting given
the extraordinary complexity of insect
societies, and addressing them
quantitatively requires simultaneously
overcoming three major technical
challenges: first, individual behavior
and social interactions should be
scored reliably and objectively.
Traditionally, behavioral studies
employ visual scan sampling of
arbitrarily defined behaviors. For
example, Wilson [5] constructed an
ethogram of 26 different behaviors in
the ant Pheidole dentata. While the
patience and meticulousness required
for such a study are admirable, the
approach is inherently error-prone
because behaviors are scored
subjectively by a human observer with
fluctuating performance. Subjective
scoring also makes it essentially
impossible for others to precisely
replicate the experiment. Furthermore,
the amount of data that can be
gathered is limited by the number of
man-hours assigned to the project.
These problems can now be
ameliorated by automated video
tracking techniques for which the
relevant parameters that define a
behavior can be mathematically
specified to ensure
reproducibility [6,7].
Second, the experimenter has to be
able to keep track of individual animals
over extended periods of time. While
this is not an issue in studies of
